Bristol-Myers Squibb completes Amira acquisition

NEW YORK — Bristol-Myers Squibb has completed its previously announced acquisition of another drug maker.

Bristol said it has completed the acquisition of small-molecule pharmaceutical company Amira Pharmaceuticals, based in San Diego, for $325 million. Amira's portfolio focuses on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases.

The transaction was originally announced on July 21.

Login or Register to post a comment.